Sanofi-a Ventis Deutschland Gmbh

Boehringer Ingelheim International Gmbh

Stada Arzneimittel Ag

Sanofi-aventis De Mexico Sa De Cv

Sandra Sauerland

Julia Elisabeth Boni

Bernd Karl Plohmann

Uwe Scheuring

Oliver Timm

Sonja Heigenhauser

Bernd Plohmann

Thomas Fuerst

Thomas Weiser

Alberto Hegewisch

Julia Boni

The present invention relates to ambroxol hydrochloride for the treatment of acute pharyngitis, wherein ambroxol hydrochloride as a sprayable composition comprising up to 30 mg/ml ambroxol hydrochloride is administered locally in a dose of 1 to 20 mg.

Use of a sprayable composition comprising ambroxol

The invention relates to water-soluble granules for preparing a drinkable solution, in particular for preventing or treating symptoms associated with mild to moderate chronic venous insufficiency of the lower extremities, containing at least 20 percent by weight of a concentrated extract of red wine leaves, and to a ready-to-use packaging unit comprising one or more portion sachets which contain the granules according to the invention.

Water-soluble granular material for producing a drinking soltuion

The present invention relates to a pharmaceutical formulation containing a combination of (a) at least one astringent active substance and (b) at least one mucilaginous drug and the use thereof for the prevention or treatment of inflammatory diseases of the oropharyngeal region and for the treatment of painful irritations of the mucosa in the oropharyngeal region and associated irritable cough.

Lozenge for treating sore throat, hoarseness and associated dry cough, and inflammatory diseases of the oral and pharyngeal cavity

Growing community of inventors

Ummendorf, Germany

Sandra Sauerland